These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25963982)

  • 41. Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an
    Cusumano JA; Daffinee KE; Piehl EC; García-Solache M; Desbonnet C; Rice LB; LaPlante KL
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0042622. PubMed ID: 36154173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
    Wagenlehner FM; Lehn N; Witte W; Naber KG
    Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
    Werth BJ; Sakoulas G; Rose WE; Pogliano J; Tewhey R; Rybak MJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):66-73. PubMed ID: 23070161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
    Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
    APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.
    Silvestri C; Cirioni O; Arzeni D; Ghiselli R; Simonetti O; Orlando F; Ganzetti G; Staffolani S; Brescini L; Provinciali M; Offidani A; Guerrieri M; Giacometti A
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1759-64. PubMed ID: 22160846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
    J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
    Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
    Steenbergen JN; Mohr JF; Thorne GM
    J Antimicrob Chemother; 2009 Dec; 64(6):1130-8. PubMed ID: 19825818
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Brown Gandt A; Griffith EC; Lister IM; Billings LL; Han A; Tangallapally R; Zhao Y; Singh AP; Lee RE; LaFleur MD
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains.
    Chen Z; Xiong Y; Tang Y; Zhao Y; Chen J; Zheng J; Wu Y; Deng Q; Qu D; Yu Z
    BMC Microbiol; 2022 Jan; 22(1):16. PubMed ID: 34996348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests.
    Campeau SA; Schuetz AN; Kohner P; Arias CA; Hemarajata P; Bard JD; Humphries RM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae.
    Hirzel C; Hirzberger L; Furrer H; Endimiani A
    Int J Antimicrob Agents; 2016 Sep; 48(3):271-6. PubMed ID: 27451085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.